000			02148 a2200577 4500
005			20250516205512.0
264		0	_c20150828
008			201508s 0 0 eng d
022			_a1537-6591
024	7		_a10.1093/cid/ciu238 _2doi
040			_aNLM _beng _cNLM
100	1		_aKojic, Erna Milunka
245	0	0	_aImmunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. _h[electronic resource]
260			_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cJul 2014
300			_a127-35 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aBrazil
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aFemale
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHIV-1 _xisolation & purification
650	0	4	_aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aPapillomaviridae _ximmunology
650	0	4	_aPapillomavirus Infections _xprevention & control
650	0	4	_aPapillomavirus Vaccines _xadverse effects
650	0	4	_aSouth Africa
650	0	4	_aUnited States
650	0	4	_aVaccination _xadverse effects
650	0	4	_aViral Load
650	0	4	_aYoung Adult
700	1		_aKang, Minhee
700	1		_aCespedes, Michelle S
700	1		_aUmbleja, Triin
700	1		_aGodfrey, Catherine
700	1		_aAllen, Reena T
700	1		_aFirnhaber, Cynthia
700	1		_aGrinsztejn, Beatriz
700	1		_aPalefsky, Joel M
700	1		_aWebster-Cyriaque, Jennifer Y
700	1		_aSaah, Alfred
700	1		_aAberg, Judith A
700	1		_aCu-Uvin, Susan
773	0		_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 59 _gno. 1 _gp. 127-35
856	4	0	_uhttps://doi.org/10.1093/cid/ciu238 _zAvailable from publisher's website
999			_c23728475 _d23728475